Amgen, Roche hematology news

The U.S. District Court for the District of Massachusetts granted a preliminary injunction to prevent Roche from selling Mircera and denied Roche's motion to overturn a jury verdict that Mircera methoxy polyethylene glycol-epoetin beta infringes Amgen's patent related to erythropoietin (EPO). Amgen is seeking a permanent injunction. ...